Method of using heparin binding motif for treating asthma
    11.
    发明授权
    Method of using heparin binding motif for treating asthma 有权
    肝素结合基序用于治疗哮喘的方法

    公开(公告)号:US08399416B2

    公开(公告)日:2013-03-19

    申请号:US13405742

    申请日:2012-02-27

    CPC classification number: C07K14/47 C12N9/22

    Abstract: The present invention is for an isolated peptide consisting of the amino acid sequence of SEQ ID NO: 9 and using the peptide for treating asthma by reducing cytotoxicity of eosinophil derived toxins in bronchial epithelial cells of the subject suffers from asthma. The method comprises preparing a pharmaceutical composition having the peptide of SEQ ID NO: 9 and administering an effective amount of the composition to the subject.

    Abstract translation: 本发明涉及由SEQ ID NO:9的氨基酸序列组成的分离的肽,并且通过降低患有哮喘的受试者的支气管上皮细胞中嗜酸性粒细胞来源的毒素的细胞毒性,并且使用该肽来治疗哮喘。 该方法包括制备具有SEQ ID NO:9的肽的药物组合物,并向受试者施用有效量的组合物。

    Process for making Biolimus A9
    14.
    发明申请
    Process for making Biolimus A9 有权
    制作Biolimus A9的方法

    公开(公告)号:US20090292118A1

    公开(公告)日:2009-11-26

    申请号:US12387754

    申请日:2009-05-08

    CPC classification number: C07D498/18

    Abstract: A process for making Biolimus A9 comprises reacting sirolimus (or rapamycin) with alkyl benzene sulfonate under the catalyzing of organic base and in the presence of organic solvent to undergo a nucleophilic substitution reaction to obtain the Biolimus A9 with high yield, not only for small-scale laboratory experiment, but also for rendering reproducibility of high yield even after process amplification.

    Abstract translation: 制备Biolimus A9的方法包括在催化有机碱和有机溶剂的存在下,使西罗莫司(或雷帕霉素)与烷基苯磺酸盐反应进行亲核取代反应,以高产率获得Biolimus A9, 即使在过程扩增后,也可以实现高产率的再现性。

    Cell Penetrating Peptides for Intracellular Delivery
    15.
    发明申请
    Cell Penetrating Peptides for Intracellular Delivery 有权
    细胞穿透肽用于细胞内递送

    公开(公告)号:US20110280798A1

    公开(公告)日:2011-11-17

    申请号:US12780497

    申请日:2010-05-14

    CPC classification number: C07K14/52 A61K38/00 C07K14/47

    Abstract: The present invention provides a cell penetrating peptide which has following sequence: NYBX1BX2BNQX3, wherein B represents a basic amino acid, X1 represents an amino acid with an aromatic, a hydrophobic or an uncharged side chain, X2 represents any amino acid, and X3 represents N or none. The present invention also provides a method for delivering a cargo into a subject by administrating a complex comprising the cell penetrating peptide and the desired cargo to the subject.

    Abstract translation: 本发明提供了具有以下序列的细胞穿透肽:NYBX1BX2BNQX3,其中B表示碱性氨基酸,X1表示具有芳香族,疏水性或不带电侧链的氨基酸,X2表示任何氨基酸,X3表示N 或无。 本发明还提供了一种通过向受试者施用包含细胞穿透肽和所需货物的复合物将货物递送到受试者中的方法。

    Process for making Biolimus A9
    16.
    发明授权
    Process for making Biolimus A9 有权
    制作Biolimus A9的方法

    公开(公告)号:US07872122B2

    公开(公告)日:2011-01-18

    申请号:US12387754

    申请日:2009-05-08

    CPC classification number: C07D498/18

    Abstract: A process for making Biolimus A9 comprises reacting sirolimus (or rapamycin) with alkyl benzene sulfonate under the catalyzing of organic base and in the presence of organic solvent to undergo a nucleophilic substitution reaction to obtain the Biolimus A9 with high yield, not only for small-scale laboratory experiment, but also for rendering reproducibility of high yield even after process amplification.

    Abstract translation: 制备Biolimus A9的方法包括在催化有机碱和有机溶剂的存在下,使西罗莫司(或雷帕霉素)与烷基苯磺酸盐反应进行亲核取代反应,以高产率获得Biolimus A9, 即使在过程扩增后,也可以实现高产率的再现性。

    METHOD OF USING HEPARIN BINDING MOTIF FOR TREATING ASTHMA
    18.
    发明申请
    METHOD OF USING HEPARIN BINDING MOTIF FOR TREATING ASTHMA 有权
    使用HEPARIN BINDING MOTIF治疗哮喘的方法

    公开(公告)号:US20120214730A1

    公开(公告)日:2012-08-23

    申请号:US13405742

    申请日:2012-02-27

    CPC classification number: C07K14/47 C12N9/22

    Abstract: The present invention is for an isolated peptide consisting of the amino acid sequence of SEQ ID NO: 9 and using the peptide for treating asthma by reducing cytotoxicity of eosinophil derived toxins in bronchial epithelial cells of the subject suffers from asthma. The method comprises preparing a pharmaceutical composition having the peptide of SEQ ID NO: 9 and administering an effective amount of the composition to the subject.

    Abstract translation: 本发明涉及由SEQ ID NO:9的氨基酸序列组成的分离的肽,并且通过降低患有哮喘的受试者的支气管上皮细胞中嗜酸性粒细胞来源的毒素的细胞毒性,并且使用该肽来治疗哮喘。 该方法包括制备具有SEQ ID NO:9的肽的药物组合物,并向受试者施用有效量的组合物。

Patent Agency Ranking